How much did Ryan Specialty repurchase in Q2 2026?

Ryan Specialty repurchased $260.0 million of Class A common stock in Q2 2026, representing 8.1 million shares at an average price of $32.10 per share. Combined with $24.5 million in dividends and distributions, total capital returned to shareholders was $284.5 million.

What is the new total buyback authorization?

The board approved an expansion of $300 million to the share repurchase program, announced on July 30, 2026. Prior to this expansion, the company had $300 million remaining under its existing authorization, resulting in increased flexibility for future repurchases.

Why is Ryan Specialty buying back shares?

The company stated that share repurchases are part of its strategy to return capital to shareholders alongside dividends. Management highlighted strong operational performance—including 7.2% revenue growth and 12.1% adjusted diluted EPS growth in Q2—supporting the company's capital allocation decisions.

What mechanism does Ryan Specialty use for buybacks?

The filing does not specify the buyback mechanism (such as Rule 10b-18 open-market purchases, accelerated share repurchase, or other methods). The company typically discloses execution details in subsequent SEC filings or earnings releases.

How does this buyback compare to the company's size?

The Q2 repurchase of $260 million represents a meaningful capital return—approximately 3.1% of the company's market capitalization based on the $32.10 execution price. The authorization expansion of $300 million provides continued capacity for future repurchases over the coming quarters or years.

Does the buyback affect Ryan Specialty's financial flexibility?

Ryan Specialty maintains $140.1 million in cash and $3.6 billion in outstanding debt as of June 30, 2026. The buyback authorization, combined with the company's operating cash flow and credit facilities, demonstrates that management believes the company has sufficient financial flexibility to repurchase shares while meeting debt obligations and funding growth investments.

RYAN 8-K Filed 2026-07-30 Amendment

Ryan Specialty expands buyback authorization by $300M; repurchased $260M in Q2

Specialty insurance firm returned $284.5M to shareholders in Q2 through stock repurchases and dividends; board expanded authorization.

Remaining$300M

MechanismNot specified

What the filing says

Ryan Specialty Holdings, Inc. (NYSE: RYAN) repurchased $260.0 million of Class A common stock in the second quarter of 2026, representing 8.1 million shares repurchased at an average price of $32.10 per share. The company returned a total of approximately $284.5 million to shareholders during the quarter, including $24.5 million in dividends and distributions.

On July 30, 2026, the company's board of directors authorized an expansion of the share repurchase program by an additional $300.0 million. As of June 30, 2026, the company had $300.0 million of remaining authorization under its share repurchase program prior to the announcement of the expansion.

The repurchases were executed as part of the company's capital allocation strategy alongside its regular dividend activity. CEO Timothy W. Turner and Founder/Executive Chairman Patrick G. Ryan highlighted the company's strong second-quarter performance, with total revenue growth of 7.2% and Adjusted Diluted EPS growth of 12.1%, supporting the continued return of capital to shareholders.

We also continued to return capital to shareholders through our dividend, repurchasing shares worth $260 million during the quarter, and expanding our repurchase authorization by an additional $300 million. — RYAN SPECIALTY HOLDINGS, INC. 8-K filing · View on SEC EDGAR →

What this means

Ryan Specialty's expansion of its repurchase authorization by $300 million signals continued confidence in the company's financial position and prospects. In Q2 2026 alone, the company repurchased 8.1 million shares at $32.10 per share, reducing the outstanding share count and supporting per-share earnings metrics. The combined $284.5 million return to shareholders—via both buybacks and dividends—represents approximately 3.1% of the company's $9.2 billion market capitalization (at the execution price). The amendment maintains flexibility for future capital deployment while the company manages its $3.6 billion debt outstanding and invests in growth initiatives in the specialty insurance market.

Frequently asked questions

How much did Ryan Specialty repurchase in Q2 2026?: Ryan Specialty repurchased $260.0 million of Class A common stock in Q2 2026, representing 8.1 million shares at an average price of $32.10 per share. Combined with $24.5 million in dividends and distributions, total capital returned to shareholders was $284.5 million.
What is the new total buyback authorization?: The board approved an expansion of $300 million to the share repurchase program, announced on July 30, 2026. Prior to this expansion, the company had $300 million remaining under its existing authorization, resulting in increased flexibility for future repurchases.
Why is Ryan Specialty buying back shares?: The company stated that share repurchases are part of its strategy to return capital to shareholders alongside dividends. Management highlighted strong operational performance—including 7.2% revenue growth and 12.1% adjusted diluted EPS growth in Q2—supporting the company's capital allocation decisions.
What mechanism does Ryan Specialty use for buybacks?: The filing does not specify the buyback mechanism (such as Rule 10b-18 open-market purchases, accelerated share repurchase, or other methods). The company typically discloses execution details in subsequent SEC filings or earnings releases.
How does this buyback compare to the company's size?: The Q2 repurchase of $260 million represents a meaningful capital return—approximately 3.1% of the company's market capitalization based on the $32.10 execution price. The authorization expansion of $300 million provides continued capacity for future repurchases over the coming quarters or years.
Does the buyback affect Ryan Specialty's financial flexibility?: Ryan Specialty maintains $140.1 million in cash and $3.6 billion in outstanding debt as of June 30, 2026. The buyback authorization, combined with the company's operating cash flow and credit facilities, demonstrates that management believes the company has sufficient financial flexibility to repurchase shares while meeting debt obligations and funding growth investments.

authorization amendment execution specialty-insurance mid-cap rule-10b-18

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.